However, the observation that cIAPs limit TNF-mediated apoptosis and that Smac-mimetics sensitize cells to TNF induced cell death [10,11,12] led to the idea that these drugs might also be used for therapeutic applications in infectious diseases. Here, TNF is linked to infectious disease.